Workflow
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
TreaceTreace(US:TMCI) GlobeNewswire News Room·2024-12-04 21:15

Core Insights - Treace Medical Concepts has successfully completed the first cases using IntelliGuide™ PSI technology with the Adductoplasty® System for personalized correction of midfoot deformities [1][2] - IntelliGuide™ PSI is the first patient-specific cut guide system in the U.S. for bunion and midfoot deformities, utilizing AI to create a pre-operative surgical plan from CT scans [2] - The company plans to progressively expand access to IntelliGuide™ for both Lapiplasty® and Adductoplasty® procedures, with a full market release expected in the first half of 2025 [2] Company Overview - Treace Medical Concepts focuses on advancing surgical treatment standards for bunions and related midfoot deformities, affecting approximately 67 million Americans, with an estimated 1.1 million being surgical candidates annually [6][7] - The company has developed the Lapiplasty® 3D Bunion Correction® System, which addresses all three planes of bunion deformities and secures the unstable joint [7] - Treace has also introduced the Adductoplasty® Midfoot Correction System and SpeedPlate™ Rapid Compression Implants to enhance surgical correction and fixation across various procedures [7] Market Position and Future Plans - The introduction of IntelliGuide™ PSI is expected to strengthen Treace's market leadership in the surgical management of bunion and midfoot deformities [3] - The company aims to build a comprehensive portfolio of digital technologies to meet the evolving needs of surgeons and patients [3] - Surgeons have expressed optimism about the potential of IntelliGuide™ PSI to revolutionize treatment approaches for complex foot deformities [3]